Subtype
Malignant Large Intestinal Neoplasm
CI-CAN-00003173Explore in graph →
1,624 active trials21 approved drugs383 evidence items
- NCIt
- C215202
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003173Explore in graph →
Clinical trials
7,504 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (742)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04005118 | Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer Surgery(Microbiota) | unknown | — | 50 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 2, 2019 | clinicaltrials |
| NCT02964468 | Dose-escalation Trial of Preoperative Radiotherapy and Concurrent Chemotherapy in Locally Advanced Rectal Cancer | unknown | N/A | 525 | Grupo de Investigación Clínica en Oncología RadioterapiaOTHER |
| 1 |
| Jun 26, 2019 |
| clinicaltrials |
| NCT03522649 | A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer | unknown | Phase 3 | 668 | 1Globe Health Institute LLCINDUSTRY | 1 | Jun 18, 2019 | clinicaltrials |
| NCT01047969 | Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy | unknown | Phase 2 | 99 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jun 13, 2019 | clinicaltrials |
| NCT03982641 | Emilia-Romagna Surgical Colorectal Cancer Audit- ESCA(ESCA) | unknown | — | 1,400 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Jun 11, 2019 | clinicaltrials |
| NCT02736942 | COLOR III Trial: Transanal vs Laparoscopic TME(COLORIII) | unknown | Phase 3 | 1,104 | Amsterdam UMC, location VUmcOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT03334383 | Trial for Retractor Sponge Evaluation in Laparoscopic Colorectal Surgery(SPONGE) | unknown | N/A | 188 | St. Antonius HospitalOTHER | 1 | May 31, 2019 | clinicaltrials |
| NCT02574013 | Randomized Controlled Trial for Retractor SPONGE Evaluation in Laparoscopic Colorectal Surgery(SPONGE) | unknown | N/A | 188 | St. Antonius HospitalOTHER | 1 | May 30, 2019 | clinicaltrials |
| NCT02877056 | Molecular Determinants of Response to Preoperative Therapy in Patients With Locally Advanced Colorectal Cancer | unknown | — | 250 | M.D. Anderson Cancer CenterOTHER | 1 | May 29, 2019 | clinicaltrials |
| NCT01092481 | Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy | unknown | Phase 3 | 1,580 | Samsung Medical CenterOTHER | 1 | May 21, 2019 | clinicaltrials |
| NCT01311856 | Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer Survivors | unknown | — | 60 | M.D. Anderson Cancer CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT01472601 | A Prospective Study of Pharmacogenetic Factors and Gene Expression Profile | unknown | — | 2,660 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT00647530 | Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery(FOxTROT) | unknown | Phase 2 / Phase 3 | 1,053 | University of BirminghamOTHER | 1 | May 17, 2019 | clinicaltrials |
| NCT03854890 | Fluorescent Lymphography-Guided Lymphadenectomy In Laparoscopic Proctectomy | unknown | N/A | 100 | Fudan UniversityOTHER | 1 | May 14, 2019 | clinicaltrials |
| NCT00354705 | Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients | unknown | — | 200 | M.D. Anderson Cancer CenterOTHER | 1 | May 10, 2019 | clinicaltrials |
| NCT03938623 | Teaching General Practitioners to Use the Patient-centered Approach When Suggesting Colorectal Cancer Screening(FORCEPS) | unknown | — | 274 | Collège de la Médecine Générale, FranceOTHER | 1 | May 6, 2019 | clinicaltrials |
| NCT03928652 | Prognostic Biomarker for CRC(PROMOTE) | unknown | — | 1,050 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Apr 26, 2019 | clinicaltrials |
| NCT03927898 | Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis | unknown | Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Apr 25, 2019 | clinicaltrials |
| NCT02861209 | Collaborative Network to Take Responsibility for Oral Anticancer Therapy(CONTACT) | unknown | N/A | 228 | KU LeuvenOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03912857 | Camrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal Cancer | unknown | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03904537 | A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer | unknown | Phase 1 / Phase 2 | 20 | Sun Yat-sen UniversityOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT01863862 | Organ Preservation in Elderly Patients With Rectal Cancer | unknown | N/A | 90 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Mar 29, 2019 | clinicaltrials |
| NCT02640781 | Comparison of Efficacy Between a Newly Designed Covered Stent and Uncovered Stent for Malignant Colorectal Obstruction | unknown | N/A | 70 | Yonsei UniversityOTHER | 1 | Mar 27, 2019 | clinicaltrials |
| NCT03880877 | Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated in Patients With Previously Treated Metastatic Colorectal Cancer | unknown | Phase 2 | 153 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Mar 21, 2019 | clinicaltrials |
| NCT03711240 | The Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver Metastases(CBL) | unknown | Phase 2 | 40 | National Cheng-Kung University HospitalOTHER | 1 | Mar 13, 2019 | clinicaltrials |
| NCT03526952 | An Internet Delivered Intervention for Re-Adjustment to Sexual Intimacy With an Ostomy After Cancer | unknown | N/A | 60 | Sunnybrook Health Sciences CentreOTHER | 1 | Mar 12, 2019 | clinicaltrials |
| NCT03868215 | Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis | unknown | — | 100 | Fudan UniversityOTHER | 1 | Mar 11, 2019 | clinicaltrials |
| NCT03436719 | Antibiotic Prophylaxis in Rectal Cancer Surgery: Oral With Intravenous Versus Intravenous Antibiotics. | unknown | N/A | 280 | State Scientific Centre of Coloproctology, Russian FederationOTHER_GOV | 1 | Mar 5, 2019 | clinicaltrials |
| NCT03422601 | Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment | unknown | — | 1,122 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT03312374 | ctDNA as a Prognostic Marker for Postoperative Relapse in Early and Intermediate Stage Colorectal Cancer | unknown | — | 350 | Sun Yat-sen UniversityOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT03468244 | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms | unknown | N/A | 24 | Changhai HospitalOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT02624726 | Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment(MINOAS) | unknown | Phase 2 | 31 | Hellenic Oncology Research GroupOTHER | 1 | Feb 22, 2019 | clinicaltrials |
| NCT03846882 | FDG - PET / MRI in Patients With Rectal Cancer(RECTOPET) | unknown | — | 100 | Region VästerbottenOTHER_GOV | 1 | Feb 20, 2019 | clinicaltrials |
| NCT02792023 | Usefulness of Fecal Immunochemical Test in Iron Deficiency Anemia (IDAFIT)(IDAFIT) | unknown | N/A | 550 | Hospital Universitario de CanariasOTHER | 1 | Feb 19, 2019 | clinicaltrials |
| NCT03843398 | Survival Outcome After Minilaparotomy for the Treatment of Colorectal Cancer(SoMiniCRC) | unknown | N/A | 992 | Changhai HospitalOTHER | 0 | Feb 18, 2019 | clinicaltrials |
| NCT03843749 | Pyrotinib in Combination With Trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar. | unknown | N/A | 30 | Shanghai Changzheng HospitalOTHER | 1 | Feb 18, 2019 | clinicaltrials |
| NCT03329183 | High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28 | unknown | Phase 2 | 90 | Shanghai Changzheng HospitalOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT03792568 | ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation. | unknown | N/A | 30 | Shanghai Changzheng HospitalOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT03828396 | Diagnosis of Colorectal Cancer and Advanced Adenoma Using Cancer-specific Methylation Signatures | unknown | — | 1,300 | Shanghai Zhongshan HospitalOTHER | 1 | Feb 4, 2019 | clinicaltrials |
| NCT02433626 | Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies(COTI2-101) | unknown | Phase 1 | 51 | Critical Outcome Technologies Inc.INDUSTRY | 1 | Feb 1, 2019 | clinicaltrials |
| NCT03826862 | Lateral Lymph Node Dissection for Middle-low Rectal Cancer | unknown | N/A | 30 | Ziqiang Wang,MDOTHER | 1 | Feb 1, 2019 | clinicaltrials |
| NCT03824899 | UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal Cancer | unknown | N/A | 100 | Fudan UniversityOTHER | 1 | Jan 31, 2019 | clinicaltrials |
| NCT03823079 | Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia | unknown | Phase 2 | 50 | Fudan UniversityOTHER | 0 | Jan 30, 2019 | clinicaltrials |
| NCT01271582 | Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients | unknown | Phase 4 | 1,500 | Asan Medical CenterOTHER | 1 | Jan 29, 2019 | clinicaltrials |
| NCT02311803 | Preservation Versus Excision of Denonvilliers Fascia in L-PANP Surgery | unknown | N/A | 172 | Third Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jan 29, 2019 | clinicaltrials |
| NCT02648386 | Stem Cell Therapy Combined With NeuroRegen Scaffold™ in Patients With Erectile Dysfunction After Rectal Cancer Surgery | unknown | Phase 1 / Phase 2 | 34 | Chinese Academy of SciencesOTHER_GOV | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03040180 | Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer(nECT) | unknown | Phase 2 | 40 | Zealand University HospitalOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03322176 | Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing | unknown | — | 200 | Data Collection Analysis Business ManagementOTHER | 1 | Jan 23, 2019 | clinicaltrials |
Data updated 24 days agoSource updated Jul 2, 2019source: clinicaltrials